Verena Paulitschke

902 total citations
29 papers, 539 citations indexed

About

Verena Paulitschke is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Verena Paulitschke has authored 29 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Immunology. Recurrent topics in Verena Paulitschke's work include Melanoma and MAPK Pathways (6 papers), Peptidase Inhibition and Analysis (5 papers) and CAR-T cell therapy research (4 papers). Verena Paulitschke is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Peptidase Inhibition and Analysis (5 papers) and CAR-T cell therapy research (4 papers). Verena Paulitschke collaborates with scholars based in Austria, Switzerland and Germany. Verena Paulitschke's co-authors include Christopher Gerner, Hubert Pehamberger, Rainer Kunstfeld, Astrid Slany, Thomas Mohr, Anastasia Meshcheryakova, Michael Mildner, Mario M. Dorostkar, Harald H. Sitte and Petra Scholze and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Verena Paulitschke

27 papers receiving 531 citations

Peers

Countries citing papers authored by Verena Paulitschke

Since Specialization

Citations

This map shows the geographic impact of Verena Paulitschke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Paulitschke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Paulitschke more than expected).

Fields of papers citing papers by Verena Paulitschke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Paulitschke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Paulitschke. The network helps show where Verena Paulitschke may publish in the future.

Co-authorship network of co-authors of Verena Paulitschke

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Paulitschke. A scholar is included among the top collaborators of Verena Paulitschke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Paulitschke. Verena Paulitschke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extracorporeal photopheresis induces the release of anti-inflammatory fatty acids and oxylipins and suppresses pro-inflammatory sphingosine-1-phosphate 2025 ·Inflammation Research ·(unknown), (unknown), (unknown), Barbara Sterniczky, Christian Jantschitsch, Dexin Dong, Andrea Bileck, Michael J. Koren, (unknown), Thomas Mohr, Robert Knobler, Wolfgang Weninger, Christopher Gerner, Verena Paulitschke	0
2	Memory effects of prior subculture may impact the quality of multiomic perturbation profiles 2024 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Andrea Bileck, Verena Paulitschke, (unknown), (unknown), Thomas Mohr, Christopher Gerner, Samuel M. Meier	3
3	Wirkweise, Indikationen und Therapieempfehlungen der extrakorporalen Photopherese (ECP) 2023 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), Verena Paulitschke, Robert Knobler	1
4	Mode of action, indications and recommendations on extracorporeal photopheresis (ECP) 2023 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), Verena Paulitschke, Robert Knobler	3
5	Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma 2021 ·Cancers ·Thomas Mohr, (unknown), Verena Paulitschke, Nadim Aizarani, Alexander Tolios	10
6	Octenidine-based hydrogel shows anti-inflammatory and protease-inhibitory capacities in wounded human skin 2021 ·Scientific Reports ·(unknown), Lukas Janker, (unknown), Michael Mildner, (unknown), Johannes Matiasek, Andrea Bileck, Christopher Gerner, Verena Paulitschke, Adelheid Elbe‐Bürger	23
7	Cutaneous manifestations of acute and chronic graft-versus-host disease 2020 ·Giornale Italiano di Dermatologia e Venereologia ·(unknown), Verena Paulitschke, Ulrike Just, Robert Knobler	5
8	Eosinophiles anuläres Erythem bei einem 20 Monate alten Mädchen 2020 ·Der Hautarzt ·Verena Paulitschke, (unknown), Adrian Tanew, Sonja Radaković	2
9	Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases 2018 ·Clinical Proteomics ·(unknown), Andrea Bileck, Besnik Muqaku, Lukas Janker, Ossia M. Eichhoff, Phil F. Cheng, Reinhard Dummer, Mitchell P. Levesque, Christopher Gerner, Verena Paulitschke	10
10	Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma 2016 ·Current Opinion in Oncology ·Verena Paulitschke, Ossia M. Eichhoff, Phil F. Cheng, Mitchell P. Levesque, Christoph Höller	7
11	Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts 2015 ·Molecular Cancer Therapeutics ·Verena Paulitschke, Walter Berger, (unknown), (unknown), Bernhard Knapp, (unknown), Dagmar Födinger, Walter Jäger, Thomas Szekeres, Anastasia Meshcheryakova, Andrea Bileck, Christine Pirker, Hubert Pehamberger, Christopher Gerner, Rainer Kunstfeld	25
12	Sphaeropsidin A shows promising activity against drug-resistant cancer cells by targeting regulatory volume increase 2015 ·Cellular and Molecular Life Sciences ·Véronique Mathieu, Aurélie Chantôme, Florence Lefranc, Alessio Cimmino, Walter Miklos, Verena Paulitschke, Thomas Mohr, Lucia Maddau, Alexander Kornienko, Walter Berger, Christophe Vandier, Antonio Evidente, Eric Delpire, Róbert Kiss	36
13	Curing advanced melanoma by 2025 2015 ·Current Opinion in Oncology ·Reinhard Dummer, Simone M. Goldinger, Verena Paulitschke, Mitchell P. Levesque	4
14	Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling 2014 ·Clinical Proteomics ·Astrid Slany, Anastasia Meshcheryakova, (unknown), Hendrik Jan Ankersmit, Verena Paulitschke, Christopher Gerner	23
15	Proteome Analysis Identified the PPARγ Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction 2012 ·PLoS ONE ·Verena Paulitschke, (unknown), (unknown), (unknown), (unknown), (unknown), Constanze Jonak, Peter Petzelbauer, Hubert Pehamberger, Christopher Gerner, Rainer Kunstfeld	23
16	Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells 2012 ·Journal of Proteomics ·(unknown), (unknown), Astrid Slany, Johannes Griss, Anastasia Meshcheryakova, Verena Paulitschke, Goran Mitulović, Johannes Stöckl, Christopher Gerner	40
17	The hsp27kD heat shock protein and p38-MAPK signaling are required for regular epidermal differentiation 2010 ·Journal of Dermatological Science ·Constanze Jonak, Michael Mildner, Gabriele Klosner, Verena Paulitschke, Rainer Kunstfeld, Hubert Pehamberger, Erwin Tschachler, Franz Trautinger	38
18	Introducing the CPL/MUW proteome database: Interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells 2009 ·Electrophoresis ·(unknown), Nina C. Gundacker, Johannes Griss, (unknown), Stefan Stättner, Thomas Mohr, Hannes Zwickl, Verena Paulitschke, David M. Baron, (unknown), Markus Kubicek, Editha Bayer, Astrid Slany, Christopher Gerner	20
19	3,3′,4,4′,5,5′-Hexahydroxystilbene Impairs Melanoma Progression in a Metastatic Mouse Model 2009 ·Journal of Investigative Dermatology ·Verena Paulitschke, (unknown), Thomas Szekeres, Walter Jäger, Leonilla Elbling, Angelika B. Riemer, Otto Scheiner, Trimurtulu Golakoti, Somepalli Venkateswarlu, Mario Mikula, (unknown), Edda Fiebiger, Christopher Gerner, Hubert Pehamberger, Rainer Kunstfeld	23
20	Two Discontinuous Segments in the Carboxyl Terminus Are Required for Membrane Targeting of the Rat γ-Aminobutyric Acid Transporter-1 (GAT1) 2004 ·Journal of Biological Chemistry ·Hesso Farhan, Volodymyr M. Korkhov, Verena Paulitschke, Mario M. Dorostkar, Petra Scholze, Oliver Kudlacek, Michael Freissmuth, Harald H. Sitte	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact